Pharmacy Residency

PGY2 Oncology Residency

The purpose of the PGY2 Oncology Pharmacy Residency is to develop graduates of a PGY1 Pharmacy Residency into clinical specialists who can successfully care for adults with cancer, including solid tumor malignancies, hematologic malignancies, those undergoing a hematopoietic cell transplant, as well as patients with benign hematological diseases. Residents who complete this program will be well equipped to handle all aspects of pharmaceutical care for oncology patients. Residents will function as part of the multi-disciplinary team and work to ensure the safe and effective use of all chemotherapy/immunotherapy. During the residency year, the resident will be responsible for the completion of a research project, exercise a variety of presentation formats, teach and precept. Multiple professional writing and research opportunities are available during the course of the year as well.

Training Site

The Hospital of the University of Pennsylvania (HUP) is world-renowned for its clinical and research excellence, forging the way for newer and better ways to diagnose and treat illnesses and disorders. HUP is a 739-bed-academic teaching hospital and tertiary referral center located in the heart of Philadelphia. Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. It is consistently ranked as one of the top hospital systems and cancer care centers in the nation. It is recognized as both a NCI-designated cancer center and FACT-accredited bone marrow and tissue transplantation center. Our clinical program, compromised of a dedicated staff of physicians, nurse practitioners, nurses, pharmacists, social workers, physical therapists, nutritionists, and patient care coordinators, currently sees over 100,000 outpatient visits, over 11,800 inpatient discharges, provides over 37,000 chemotherapy treatments, and more than 66,000 radiation treatments. Not only are we dedicated to providing state-of-the-art cancer care, the latest forms of cancer prevention, diagnosis, and treatment are available to our patients through clinical themes that developed in the relentless pursuit to eliminate the pain and suffering from cancer. Together, our faculty is committed to improving the prevention, diagnosis, and treatment of cancer. HUP's reputation as a world leader in medical research and clinical care attracts the highest quality medical specialists from around the world. The supportive and collaborative environment encourages physicians and staff to keep reaching ahead to find new ways to improve the quality and length of life for everyone.

Learning Experiences

Required Rotations

  • Orientation – 1 month
    • Typically consists of Hospital and department training in addition to pharmacokinetic training, code training and an oncology “boot camp” learning series. BLS and ACLS will be scheduled during this time if not already certified. The resident will also be trained on the pharmacy teams covering the oncology care units, as this is where their primary weekend staffing responsibility will fall. Prior to beginning PGY2 rotations, the resident will become familiarized with chemotherapy policies, procedures and safe handling of hazardous agents.
  • Medical Oncology – 1 month
  • Malignant Hematology – 2 months
  • Allogeneic Transplantation – 1 month
  • Autologous Transplantation – 1 month
  • Ambulatory Care – 2 months
  • Symptom Management and Palliative Care – 1 month
  • Research – 1 month
  • Infectious Diseases in the Oncology Population – 1 month

Electives (1 month)

In addition to the required residency rotations, elective rotations in several oncology-related areas are available to enhance the resident’s experience and knowledge. Any of the above listed rotations may be used as elective rotations. Listed below are some additional elective rotations available:

  • Gynecology/Oncology
  • Benign Hematology
  • Nutrition support
  • Pediatric Oncology

Longitudinal Experiences

  1. Assist in the mentoring and act a pharmacy role model to pharmacy students, PGY1 residents, and pharmacy staff.
  2. Act as an oncology resource for physicians, nurses, pharmacists, and patients.
  3. Act as an integral part of the team taking care of patients in an outpatient clinic setting by providing education to nurses, physicians, and patients in that setting.
  4. Provide educational in-services to the nursing staff, house-staff officers, and other staff in the pharmacy department on oncology specific issues including but not limited to: new drug treatments, adverse effects, new guidelines for supportive care in patients with cancer, and proper administration of chemotherapy.
  5. Participate in department, hospital and clinical unit committees as assigned. Also serve as secretary of assigned Pharmacy-led interdisciplinary committee (Pharmacy and Therapeutics, Medication Safety, etc.).
  6. Participate actively on a multi-disciplinary team caring for patients who have hematologic or solid tumor malignancies, those receiving immunotherapy, or those who have received or are receiving a hematopoietic stem cell transplant.
  7. Participate in formulary decisions regarding oncology specific agents such as new chemotherapy agents and supportive care medications for use in patients with cancer.
  8. Prepare drug monographs (2 required) for formulary review, drug or therapeutic guidelines and drug utilization reviews as needed.
  9. Work to improve the medication use policies relating to chemotherapy and ensure the safe use of all chemotherapy in both the inpatient and outpatient setting.
  10. Participate in the clinical intervention program, adverse drug reaction reporting program and medication error program.
  11. Actively be involved in medication reconciliation at admission and discharge for all patients in the oncology setting
  12. Be involved with investigational protocols for patients in the inpatient setting and to understand the processes involved in safely preparing and distributing investigational agents in the outpatient setting
  13. Provide weekend staffing coverage and pharmacokinetics service coverage to an oncology practice area.
  14. Present journal clubs and patient case presentations as part of the Residency Program’s Therapeutics Conference.
  15. Certify in Basic Life Support and Advanced Cardiac Life Support. Respond to Code Call, Anesthesia Stat and Rapid Response requests as assigned.
  16. Present an oncology disease state topic discussion at least once a month as part of the oncology education series.
  17. Deliver a pharmacy continuing education presentation to members of the pharmacy department.
  18. Completion of an oncology-focused PGY1-paired research project.
  19. Present a poster presentation of the methodology of the research project at UHC. The PGY1 resident will present the poster at The Mid-year clinical meeting.
  20. Submission of research project manuscript to a peer-reviewed oncology journal.
  21. Submit an abstract for poster presentation (research project) to HOPA or other national meeting.
  22. Attend the Mid-year clinical meeting, Eastern States Residency Conference (optional), and HOPA Annual Meeting, as funding allows.
  23. Present HOPA journal club during residency year. (optional)
  24. Participate in writing a review article. (optional)
  25. Instruct pharmacy students in didactic coursework or other academic setting. (optional)
  26. Participate in the Teaching Certificate Program. (optional)

Program Director

Colleen Timlin, PharmD, BCOP
Clinical Pharmacy Specialist, Hematology/Oncology
Hospital of the University of Pennsylvania
3400 Spruce Street
Ground Rhoads
Philadelphia, PA 19104
colleen.timlin@uphs.upenn.edu